BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20377369)

  • 1. Equine infectious anemia viral vector-mediated codelivery of endostatin and angiostatin driven by retinal pigmented epithelium-specific VMD2 promoter inhibits choroidal neovascularization.
    Kachi S; Binley K; Yokoi K; Umeda N; Akiyama H; Muramatu D; Iqball S; Kan O; Naylor S; Campochiaro PA
    Hum Gene Ther; 2009 Jan; 20(1):31-9. PubMed ID: 20377369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EIAV vector-mediated delivery of endostatin or angiostatin inhibits angiogenesis and vascular hyperpermeability in experimental CNV.
    Balaggan KS; Binley K; Esapa M; MacLaren RE; Iqball S; Duran Y; Pearson RA; Kan O; Barker SE; Smith AJ; Bainbridge JW; Naylor S; Ali RR
    Gene Ther; 2006 Aug; 13(15):1153-65. PubMed ID: 16572190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of neovascularization of donor corneas by transduction with equine infectious anemia virus-based lentiviral vectors expressing endostatin and angiostatin.
    Parker M; Bellec J; McFarland T; Scripps V; Appukuttan B; Hartzell M; Yeager A; Hady T; Mitrophanous KA; Stout T; Ellis S
    Hum Gene Ther; 2014 May; 25(5):408-18. PubMed ID: 24460027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study.
    Campochiaro PA; Lauer AK; Sohn EH; Mir TA; Naylor S; Anderton MC; Kelleher M; Harrop R; Ellis S; Mitrophanous KA
    Hum Gene Ther; 2017 Jan; 28(1):99-111. PubMed ID: 27710144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of Choroidal Neovascularization in Mice by Subretinal Delivery of Multigenic Lentiviral Vectors Encoding Anti-Angiogenic MicroRNAs.
    Askou AL; Benckendorff JNE; Holmgaard A; Storm T; Aagaard L; Bek T; Mikkelsen JG; Corydon TJ
    Hum Gene Ther Methods; 2017 Aug; 28(4):222-233. PubMed ID: 28817343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-specific gene therapy driven by an optimized hypoxia-regulated vector reduces choroidal neovascularization.
    Biswal MR; Prentice HM; Smith GW; Zhu P; Tong Y; Dorey CK; Lewin AS; Blanks JC
    J Mol Med (Berl); 2018 Oct; 96(10):1107-1118. PubMed ID: 30105447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of gene therapy for treatment of age-related macular degeneration.
    Askou AL
    Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EIAV-based retinal gene therapy in the shaker1 mouse model for usher syndrome type 1B: development of UshStat.
    Zallocchi M; Binley K; Lad Y; Ellis S; Widdowson P; Iqball S; Scripps V; Kelleher M; Loader J; Miskin J; Peng YW; Wang WM; Cheung L; Delimont D; Mitrophanous KA; Cosgrove D
    PLoS One; 2014; 9(4):e94272. PubMed ID: 24705452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Hypoxia-Regulated Retinal Pigment Epithelium-Specific Gene Therapy Vector Reduces Choroidal Neovascularization in a Mouse Model.
    Yuan Y; Kong W; Liu XM; Shi GH
    Curr Gene Ther; 2022; 22(5):417-426. PubMed ID: 35382718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of photoreceptor-specific promoters and their utility to investigate EIAV lentiviral vector mediated gene transfer to photoreceptors.
    Nicoud M; Kong J; Iqball S; Kan O; Naylor S; Gouras P; Allikmets R; Binley K
    J Gene Med; 2007 Dec; 9(12):1015-23. PubMed ID: 17963276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and biodistribution of an equine infectious anemia virus-based gene therapy, RetinoStat(®), for age-related macular degeneration.
    Binley K; Widdowson PS; Kelleher M; de Belin J; Loader J; Ferrige G; Carlucci M; Esapa M; Chipchase D; Angell-Manning D; Ellis S; Mitrophanous K; Miskin J; Bantseev V; Nork TM; Miller P; Naylor S
    Hum Gene Ther; 2012 Sep; 23(9):980-91. PubMed ID: 22716662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained expression after nonviral ocular gene transfer using mammalian promoters.
    Kachi S; Esumi N; Zack DJ; Campochiaro PA
    Gene Ther; 2006 May; 13(9):798-804. PubMed ID: 16467860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of VEGF in retinal pigmented epithelial cells is not sufficient to cause choroidal neovascularization.
    Oshima Y; Oshima S; Nambu H; Kachi S; Hackett SF; Melia M; Kaleko M; Connelly S; Esumi N; Zack DJ; Campochiaro PA
    J Cell Physiol; 2004 Dec; 201(3):393-400. PubMed ID: 15389527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization.
    Gehlbach P; Demetriades AM; Yamamoto S; Deering T; Duh EJ; Yang HS; Cingolani C; Lai H; Wei L; Campochiaro PA
    Gene Ther; 2003 Apr; 10(8):637-46. PubMed ID: 12692592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal Inhibition of Choroidal Neovascularization by scAAV2 with VMD2 Promoter-driven Active Rap1a in the RPE.
    Wang H; Kunz E; Stoddard GJ; Hauswirth WW; Hartnett ME
    Sci Rep; 2019 Oct; 9(1):15732. PubMed ID: 31673119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization.
    Mori K; Gehlbach P; Yamamoto S; Duh E; Zack DJ; Li Q; Berns KI; Raisler BJ; Hauswirth WW; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1994-2000. PubMed ID: 12037010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of the disease phenotype in the mouse model of Stargardt disease by lentiviral gene therapy.
    Kong J; Kim SR; Binley K; Pata I; Doi K; Mannik J; Zernant-Rajang J; Kan O; Iqball S; Naylor S; Sparrow JR; Gouras P; Allikmets R
    Gene Ther; 2008 Oct; 15(19):1311-20. PubMed ID: 18463687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trophic activity of Rabies G protein-pseudotyped equine infectious anemia viral vector mediated IGF-I motor neuron gene transfer in vitro.
    Teng Q; Garrity-Moses M; Federici T; Tanase D; Liu JK; Mazarakis ND; Azzouz M; Walmsley LE; Carlton E; Boulis NM
    Neurobiol Dis; 2005 Dec; 20(3):694-700. PubMed ID: 16005636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin.
    Mori K; Ando A; Gehlbach P; Nesbitt D; Takahashi K; Goldsteen D; Penn M; Chen CT; Mori K; Melia M; Phipps S; Moffat D; Brazzell K; Liau G; Dixon KH; Campochiaro PA
    Am J Pathol; 2001 Jul; 159(1):313-20. PubMed ID: 11438478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of choroidal neovascularization by adeno-associated virus vector expressing angiostatin.
    Lai CC; Wu WC; Chen SL; Xiao X; Tsai TC; Huan SJ; Chen TL; Tsai RJ; Tsao YP
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2401-7. PubMed ID: 11527956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.